Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Immunology
47%
Epitope
42%
Human Immunodeficiency Virus
42%
Neutralization
32%
T-Helper Cell
26%
Glycan
24%
CD4
19%
Monoclonal Antibody
19%
Immune Complex
16%
Antibody Response
16%
Neutralizing Antibody
15%
Cytotoxic T Cell
15%
Glycoprotein
14%
Cladistics
12%
Human Immunodeficiency Virus Infection
11%
Immunogenicity
10%
HIV Type 1
10%
Virus Neutralization
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Synapse
9%
T Cell
9%
Lectin
9%
Human Monoclonal Antibody
8%
Antigen Presentation
8%
Binding Site
8%
Target Cell
8%
Titer
7%
Blood Plasma
7%
Lymphocyte Function-Associated Antigen 1
7%
Peptides
7%
Glycosylation
7%
Spike
7%
Wild Type
6%
Antibodies
6%
Hemagglutinin
6%
Antigenicity
6%
COVID-19
5%
T Cell Receptor
5%
Keyphrases
Human Immunodeficiency Virus Type 1 (HIV-1)
67%
Gp120
42%
HIV-1 Envelope
33%
Epitope
33%
Virus
27%
Envelope gp120
24%
Monoclonal Antibody
22%
Immune Complex
14%
V1V2
14%
Antibody Response
13%
HIV Envelope
12%
Glycans
12%
Virus Neutralization
12%
Glycoprotein 120
12%
Cytotoxic T Lymphocytes
12%
Neutralizing Activity
11%
CD4 T Cells
11%
V3 Loop
10%
Ligand-binding Domain
10%
CD4+ T Cells
9%
COVID-19
9%
Cytotoxic T Cells
8%
Vaccination
8%
Neutralizing Antibodies
8%
HIV Infection
8%
Virological Synapse
8%
(I)-envelope
8%
CD4 Binding
8%
Anti-CD4
8%
Primary Isolates
8%
Neutralizing Epitope
7%
Lectin
7%
LFA-1
7%
Glycan Composition
6%
CD4-binding Site
6%
HIV Vaccine
6%
Viral Glycoprotein
6%
Antigen Presentation
6%
Synthetic Peptides
6%
Immunization
6%
HIV Patients
6%
Neutralization Activity
6%
N-glycan
5%
Immunogenicity
5%
AIDS/HIV
5%
Glycosylation
5%
MHC Class II
5%
Functional Antibodies
5%
